(Q37942650)

25 August 2017

1 reference

title

Late HIV presentation: epidemiology, clinical implications and management (English)

1 reference

25 August 2017

1 reference

Caroline A Sabin

2

0 references

author name string

Laura Waters

series ordinal

1

1 reference

25 August 2017

1 October 2011

1 reference

Expert Review of Anti-infective Therapy

25 August 2017

1 reference

25 August 2017

9

1 reference

25 August 2017

10

1 reference

25 August 2017

877-889

1 reference

HIV positive patients first presenting with an AIDS defining illness: characteristics and survival

25 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

HIV transmission and high rates of late diagnoses among adults aged 50 years and over

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

The economic burden of late entry into medical care for patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late presenters in an HIV surveillance system in Italy during the period 1992-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: a case-case comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late diagnosis of HIV infection: the role of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Clinical and laboratory profile of HIV-positive patients at the moment of diagnosis in Bahia, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late diagnosis of HIV infection at two academic medical centers: 1994-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Determinants and prevalence of late HIV testing in Tijuana, Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Newly diagnosed HIV infections: review in UK and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

The therapeutic implications of timely linkage and early retention in HIV care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late presentation for human immunodeficiency virus care in the United States and Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 μl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Delayed Presentation and Late Testing for HIV: Demographic and Behavioral Risk Factors in a Multicenter Study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Delayed presentation for human immunodeficiency virus (HIV) care among veterans: a problem of access or screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Delayed first consultation after diagnosis of HIV infection in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Definition and epidemiology of late presentation in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late presentation of HIV infection: a consensus definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Factors associated with delayed entry into primary HIV medical care after HIV diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Predictors of AIDS-defining events among advanced naïve patients after HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Hospitalization risk following initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Contemporary costs of HIV healthcare in the HAART era

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Medical and societal consequences of late presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Management of late-presenting patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Timing of initiation of antiretroviral drugs during tuberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Correlates of lending needles/syringes among HIV-seropositive injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Interleukin-2 therapy in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Survival after neuroAIDS: Association with antiretroviral CNS Penetration-Effectiveness score

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Prevalence and factors associated with renal dysfunction among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Earlier testing for HIV--how do we prevent late presentation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

The impact of provider-initiated (opt-out) HIV testing and counseling of patients with sexually transmitted infection in Cape Town, South Africa: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

A randomised controlled study of mouth swab testing versus same day blood tests for HIV infection in young people attending a community drug service

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

HIV testing strategies across European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Increased HIV testing and reduced undiagnosed infection among gay men in Scotland, 2005-8: support for the opt-out testing policy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Should blood-borne virus testing be part of operative consent? When the doctor becomes the patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993–2002)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Late HIV diagnosis and delay in CD4 count measurement among HIV-infected patients in Southern Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Efficacy and safety by baseline HIV-RNA and CD4 count in treatment-naive patients treated With atazanavir/r and lopinavir/r in the CASTLE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

Clinical effect of interleukin-2 (IL-2) immuno-adjuvant treatment in HIV+ advanced naïve patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

O422 Do the disadvantages of late initiation of HAART persist in patients achieving and maintaining viral load (VL) suppression for a year on HAART?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.11.106

21 January 2018

Identifiers

DOI

10.1586/ERI.11.106

1 reference

25 August 2017

1 reference

PubMed ID

21973300